This finding also reinforces that a glioma demonstrating T2-FLAIR mismatch should be considered an IDH-mutant astrocytoma even in the context of negative IDH1-R132H immunohistochemistry, with a non-canonical IDH mutation being likely. Here, IDH1 is linked to glioma.